C.129P2-Fcgr1tm1Jsv/Cnrm
Status | Available to order |
EMMA ID | EM:01744 |
International strain name | C.129P2-Fcgr1tm1Jsv/Cnrm |
Alternative name | CD64 (Balb/C) 376 |
Strain type | Targeted Mutant Strains : Knock-out |
Allele/Transgene symbol | Fcgr1tm1Jsv, |
Gene/Transgene symbol | Fcgr1 |
Information from provider
Provider | Verbeek J.S. Verbeek J.S. |
Provider affiliation | Leiden University Medical Center |
Genetic information | Deletion of 3'-part of promoter, exon 1 (L1 domain), exon 2 (L2 domain) and 5'-part of exon 3 (ligand binding EC1 domain), replaced by a PGK-hygromycin resistance cassette. |
Phenotypic information | Impaired IgG2a (and IgG2b) antibody effector pathways. |
References |
|
Information from EMMA
Archiving centre | CNR, Consiglio Nazionale delle Ricerche, Monterotondo, Italy |
Literature references
- FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection.;Ioan-Facsinay A, de Kimpe S J, Hellwig S M M, van Lent P L, Hofhuis F M A, van Ojik H H, Sedlik C, da Silveira S A, Gerber J, de Jong Y F, Roozendaal R, Aarden L A, van den Berg W B, Saito T, Mosser D, Amigorena S, Izui S, van Ommen G J B, van Vugt M, van de Winkel J G J, Verbeek J S, ;2002;Immunity;16;391-402; 11911824
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).